The US Food and Drug Administration (FDA) has approved Mirvaso (brimonidine) topical gel, produced by Galderma Laboratories, for the topical treatment of the facial erythema (redness) of Rosacea in adults with 18 years or above. With a 12 ...
Tags: Facial Redness, Treatment
Lupin Pharmaceuticals has gained tentative FDA approvals for Armodafinil tablets, 50mg, 100mg, 150mg, 200mg and 250mg strengths in addition to Doxycycline capsules, 40mg (30mg immediate-release and 10mg delayed-release). Armodafinil ...
Galderma Laboratories has gained US marketing rights for its Epiduo (adapalene 0.1%/BPO 2.5%) Gel, designed for the treatment of acne in children as young as nine years old, following the approval from the US Food and Drug Administration ...
The US Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Nuvo Research's Pliaglis (lidocaine/tetracaine) 7%/7% cream. Pliaglis, a topical local anesthetic cream forms a pliable peel on the skin ...